510(k) K092603
K092603 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "COBAS INTEGRA GLUCOSE HK GEN 3 ASSAY". The FDA issued a decision of Substantially Equivalent on Dec 4, 2009. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Roche Diagnostics has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 4, 2009
- Date Received
- Aug 25, 2009
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.